Ça brasse...ça s'énerve..."made in Qc"

Rare sont les stocks Québecois qui brasse la cage du coté Américain.

Labopharm semble vouloir énerver nos amis ..... et en fin de compte....ça énerve tout le monde.DDSS .nasdaq DDS.to

http://www.labopharm.com/

Labopharm jumped by 23 cents, or 9.6%, to $2.63 after Canadian healthcare Web site BIO tuesday posted an interview with Labopharm CEO James Howard-Tripp, where he called the company's new antidepressant trazodone "a game-changer for us." The Food and Drug Administration is expected to approve trazodone by Feb. 11.

http://biotuesday.ca/2010/01/26/labopharm%E2%80%99s-new-antidepressant-to-be-%E2%80%98game-changer%E2%80%99/